What You Need to Know About Apellis Pharmaceuticals' 2025 Board Appointment

Apellis Pharmaceuticals announced a new board member in 2025, but the company has not yet disclosed the full details of the appointment

As of early 2025, Apellis Pharmaceuticals has signaled changes to its board of directors, but the specific name, background, and appointment date have not been made public through standard corporate channels. The company typically announces board appointments through press releases, SEC filings, and investor relations statements. If you are tracking this appointment for investment research, employment purposes, or general corporate news, you will need to check the company's official sources rather than rely on preliminary reports.

Apellis is a publicly traded biopharmaceutical company focused on complement-based therapies. Board appointments at public companies are matters of public record once they are official, but the timing and details of announcements can vary. The company files information about board composition with the Securities and Exchange Commission (SEC) in its proxy statements and annual reports.

Key Takeaways

• Apellis Pharmaceuticals board appointments are disclosed through SEC filings, press releases, and the company's investor relations website.
• The most reliable source for confirmed board appointment information is the company's official proxy statement (DEF 14A), filed annually with the SEC.
• You can search for Apellis filings and board information on the SEC's EDGAR database at no cost.
• If you need current board composition for employment, investment, or research purposes, contact Apellis investor relations directly rather than relying on unconfirmed reports.

Where to find official board appointment announcements

Apellis Pharmaceuticals publishes board changes through its investor relations department. The company maintains a website where it posts press releases, and these announcements typically include the new board member's name, professional background, and the effective date of the appointment.

The SEC's EDGAR database is the authoritative source for all public company board information. When Apellis files its annual proxy statement (the document sent to shareholders before the annual meeting), it lists every board member, their roles, and their professional history. This filing is free to access and searchable by company name.

You can also check Apellis's investor relations contact page to request current board information directly. Many companies maintain a "Board of Directors" page on their corporate website with photos, biographies, and appointment dates.

How to search the SEC EDGAR database for board information

Go to www.sec.gov/cgi-bin/browse-edgar. Enter "Apellis Pharmaceuticals" in the company search field. The database will return all filings associated with the company.

Look for the most recent DEF 14A filing — this is the proxy statement filed before the annual shareholder meeting. Open the document and search for "Board of Directors" or "Director Nominees." This section lists all current board members, their appointment dates, and their professional backgrounds.

If you want to track when the appointment was announced, search for 8-K filings (current reports of material events). A board appointment may be disclosed in an 8-K before it appears in the full proxy statement. The 8-K will show the exact date the company made the announcement public.

What information is included in a board appointment announcement

When Apellis announces a new board member, the company typically discloses the person's name, professional title, relevant experience, and the date the appointment becomes effective. The announcement may also specify which board committees the new member will join — such as audit, compensation, or nominating committees.

Press releases often include a quote from the board chair or CEO explaining why the appointment strengthens the board. This context can help you understand the company's strategic priorities and what expertise the new member brings.

SEC filings go further, requiring disclosure of any business relationships between the new board member and the company, as well as any potential conflicts of interest. This information protects shareholders by ensuring transparency about board independence.

Why board appointments matter and who needs to know

Board members set company strategy, oversee management, and make decisions about major investments and executive compensation. A new appointment can signal changes in company direction, especially if the person brings expertise in a new area — such as regulatory affairs, manufacturing, or international expansion.

Investors track board changes because they affect company governance and risk management. Employees may care about board appointments if they signal new leadership priorities or potential restructuring. Job seekers in the pharmaceutical industry sometimes monitor board changes to understand which companies are growing or shifting focus.

Journalists, analysts, and researchers use board appointment information to report on corporate leadership trends and individual executives' career moves across the industry.

What to do if you cannot find the appointment details

If the appointment has been announced but you cannot locate it through SEC filings or the company website, contact Apellis Pharmaceuticals' investor relations team directly. Most public companies have a dedicated phone line and email address for investor inquiries. You can find this contact information on the company's investor relations page.

If the appointment has not yet been officially announced, you may be seeing preliminary or unconfirmed reports. Wait for an official press release or SEC filing before treating the information as confirmed. Corporate board appointments sometimes leak to the press before formal announcement, but the details can change.

You can also set up alerts through the SEC EDGAR system to receive notifications when Apellis files new documents. This ensures you see announcements as soon as they become public record.

Frequently Asked Questions

Where can I find Apellis Pharmaceuticals' current board members?

The most current list is in the company's latest proxy statement (DEF 14A), available free on the SEC EDGAR database. You can also visit Apellis's corporate website and look for the "Board of Directors" or "Leadership" page, which usually includes photos and biographies of all current board members.

How long does it take for a board appointment to be announced publicly?

Companies typically announce board appointments immediately or within a few days of the decision. The announcement appears in a press release and is filed with the SEC. However, the full details may not appear in the annual proxy statement until the next shareholder meeting, which can be several months away.

Can I find information about board members' compensation?

Yes. The proxy statement includes a section on director compensation that shows how much each board member is paid, what form the payment takes (cash, stock, or both), and any additional benefits. This information is public and searchable in the SEC EDGAR database.

What if I want to know why a board member was appointed?

The press release announcing the appointment usually includes a statement from company leadership explaining the new member's background and why they were chosen. The proxy statement may also include information about the board's composition strategy and what skills or experience the company was seeking.

How do I stay updated on future Apellis board changes?

Set up an alert on the SEC EDGAR website for Apellis Pharmaceuticals to receive notifications when new filings are posted. You can also follow the company's investor relations social media accounts or subscribe to their email updates, which often include announcements of board changes and other corporate news.